Seldin and collaborators show that primary HAECs treated with TMAO express higher levels of ICAM-1 and E-selectin, prompting TMAO as an inducer of adhesion molecules involved in the late endothelial dysfunction [75]. This evidence concerns the gene ICAM1 and endothelial dysfunction.